Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERITINIB vs CERTOLIZUMAB PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CERITINIB vs CERTOLIZUMAB PEGOL: Safety Overview

Metric CERITINIB CERTOLIZUMAB PEGOL
Total FAERS Reports 2,796 99,098
Deaths Reported 786 5,361
Death Rate 28.1% 5.4%
Hospitalizations 804 17,641
Average Patient Age 55.6 yrs 49.5 yrs
% Female Patients 55.1% 83.1%
FDA Approval Date Apr 29, 2014 N/A
Manufacturer Novartis Pharmaceuticals Corporation UCB, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued Prescription